NEWS
国立健康危機管理研究機構臨床研究センターチームによる論文がHuman Vaccines & Immunotherapeuticsにアクセプトされました：Ishiguro C*, Morita H, Mimura W, Tsuzuki S, Hirashima J, Takeuchi Y, Oda F, Maeda M, Fukuda H. Safety monitoring of Bivalent, Quadrivalent, and 9-valent Human Papillomavirus Vaccination in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study. Human Vaccines & Immunotherapeutics 2026; in press.